Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 20, 1999

View Archived Issues

Elan Submits NeuroBloc PLA; Plans Launch Later This Year

ForBio Aims To Raise US$25M, Move To Nasdaq Exchange

Blocking CB1 Receptor May Help With Drug Withdrawal

Proteome Sciences Develops Way To Reprogram mRNA

Actinova, Hospitals Team Up To Push Tooth-Decay Peptide

Flamel, Corning Widen Agreement For Polymers

Shield, Axis Plan Merger For Cardiovascular Tests

RPR, Affymetrix Sign Deal For GeneChip Technology

Trinity Biotech To Seek Secondary Stock Listing

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.